Radhika Mereddy
About Radhika Mereddy
Radhika Mereddy, 49, joined Syra Health’s Board in August 2025 and is a Senior Systems Manager at the Pension Fund of the Christian Church, where she has held roles of increasing responsibility since 2013 . She holds a Master’s degree in Management Information Systems from Ferris State University and a Bachelor’s in engineering from PDA Engineering College, with a profile emphasizing information systems and business process improvement .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Pension Fund of the Christian Church | Senior Systems Manager | Since 2013 | Information systems and process improvement; technology leverage for reliability and speed |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Not disclosed | — | — | No other public company directorships or committee roles disclosed in SYRA proxy biography |
Board Governance
- Board independence review in 2025 named three independent directors (Vijayapal Reddy, Ketan Paranjape, Avutu Reddy); Mereddy was not listed in that independent cohort, and her independence status was not explicitly disclosed .
- As of December 31, 2024, committee membership was: Audit (Rogers—Chair; Paranjape; Avutu Reddy), Compensation (Avutu Reddy—Chair; Vijayapal Reddy), Nominating & Governance (Vijayapal Reddy—Chair; Avutu Reddy); Mereddy joined in August 2025 and no committee assignment was disclosed for her in the 2025 proxy .
- Board leadership structure: no Chairman of the Board disclosed for 2025 .
- Attendance context: In 2024, the Board held 8 meetings; none of the directors attended fewer than 75% of combined Board/committee meetings during their tenure; Mereddy was not a director in 2024, and no attendance data was disclosed for her .
Fixed Compensation
Non-employee director cash compensation policy approved March 26, 2025 (applicable during Mereddy’s tenure):
| Component | Amount (USD) | Notes |
|---|---|---|
| Annual cash retainer (non-employee directors) | $20,000 | Paid in quarterly installments |
| Audit Committee Chair | $10,000 | Additional annual cash compensation |
| Compensation Committee Chair | $5,000 | Additional annual cash compensation |
| Nominating & Governance Committee Chair | $5,000 | Additional annual cash compensation |
| Committee membership fee (each committee) | $2,000 | Additional annual cash compensation |
- Actual amounts earned by Mereddy in 2025 were not itemized in the proxy; policy terms above apply to non-employee directors .
Performance Compensation
- No performance-based metrics were disclosed for director compensation; 2025 policy describes cash retainers and chair/member fees without equity or metric-linked pay .
Context: 2024 option grants to then-serving directors (Mereddy was not yet on the Board)
| Director | Grant Date | Options (#) | Exercise Price | Term | Vesting |
|---|---|---|---|---|---|
| Andrew Dahlem | Nov 14, 2024 | 11,581 | $0.3683 | 10 years | 25% at grant; remainder in 12 equal monthly installments |
| Ketan Paranjape | Nov 14, 2024 | 19,303 | $0.3683 | 10 years | As above |
| Avutu Reddy | Nov 14, 2024 | 15,442 | $0.3683 | 10 years | As above |
| Vijayapal Reddy | Nov 14, 2024 | 15,442 | $0.3683 | 10 years | As above |
| Sherron Rogers | Nov 14, 2024 | 11,581 | $0.3683 | 10 years | As above |
Other Directorships & Interlocks
- No other public company board service or disclosed interlocks for Mereddy in SYRA’s 2025 proxy .
Expertise & Qualifications
- Education: Master’s in MIS (Ferris State University); Bachelor’s in engineering (PDA Engineering College) .
- Functional expertise: information systems and business process improvement; leveraging technology and information to drive reliability and speed .
Equity Ownership
- Beneficial ownership (as of September 17, 2025): Mereddy reported no Class A or Class B holdings in the beneficial ownership table .
- Ownership alignment context: Directors are subject to an anti-hedging policy; pledging requires specific exception by the chief compliance officer, mitigating misalignment risks from hedging/pledging practices .
| Holder | Class A Shares | Class B Shares | Voting Power (%) |
|---|---|---|---|
| Radhika Mereddy | 0 | 0 | Not listed (table shows “—” for her) |
Insider Trades
| Date Range | Filing(s) | Notes |
|---|---|---|
| FY2024 | Section 16(a) delinquency disclosures | Only Priya Prasad was noted for one late Form 4; Mereddy was not listed among delinquent filers |
Governance Assessment
- Independence and committee role clarity: Mereddy is a new director (Aug 2025) and was not named in the independence cohort disclosed (three of five directors); lack of explicit independence confirmation and unspecified committee assignments reduce transparency on her oversight role and board effectiveness for 2025 .
- Ownership alignment: As of Sept 17, 2025, Mereddy reported no beneficial ownership, which, combined with 2025 cash-only director compensation structure, suggests limited direct alignment via equity unless grants occur later .
- Anti-hedging policy: The company’s policy prohibits hedging and derivative transactions and restricts pledging, supporting alignment and investor confidence; exceptions to pledging require demonstrable repayment capacity without resort to pledged securities .
- Dual-class governance changes (RED FLAG for entrenchment risk): 2025 proposals remove automatic conversion of Class B upon a holder’s death and permit transfers of Class B to family, heirs, successors, and assigns without conversion—potentially preserving super-voting control across generations and affecting voting dynamics and long-term shareholder composition .
- Related-party environment: The company disclosed related-party transactions with entities associated with certain executives and affiliates (e.g., STVentures lease; RAD CUBE; NLogix; STLogics advances) but none specifically involving Mereddy; these arrangements warrant continued audit committee scrutiny to avoid conflicts .
- Attendance culture: Board met 8 times in 2024 and directors met attendance thresholds; no data disclosed yet for Mereddy given her 2025 appointment .
Overall signal: Mereddy brings systems and process expertise relevant to technology-enabled healthcare operations, but current disclosures provide limited clarity on her independence, committee roles, and equity alignment; coupled with dual-class amendments that may entrench control, investors should monitor her future committee assignments, any equity grants, and Section 16 filings to assess governance alignment and engagement .